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Current Rural Drug Use in the US Midwest
Abstract
The nature and challenge of illicit drug use in the United States continues to change
rapidly, evolving in reaction to myriad social, economic, and local forces. While
the use of illicit drugs affects every region of the country, most of our current
information about drug use comes from large urban areas. Data on rural drug
use and its harms justify greater attention. Record overdose rates, unexpected
outbreaks of HIV, and a dearth of treatment facilities point to a rapidly worsening
health situation. While health sciences have made considerable progress in
understanding the etiology of drug use and uncovering the link between drug
use and its myriad associated harms, this promising scientific news has not
always translated to better health outcomes. The scope of the problem in the
Central Plains of the US is growing, and can be estimated from available sources.
Clear remedies for this rising level of abuse are available, but few have been
implemented. Suggestions for short-term policy remedies are discussed.
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Introduction
The use of illicit drugs affects every region of the United States,
but most of our information about drug use comes from large
urban areas [1]. This is true despite two decades of increasingly
visible rural drug use and its related harms [2, 3]. While once
restricted to southern California, methamphetamine has had
its largest impacts in rural states such as Oklahoma, Iowa, and
Missouri [4]. More recently, Nebraska has joined this list, with
increasing evidence of following in its neighbor’s footsteps. The
most recent Centers for Disease Control and Prevention data
for Nebraska reveal that substance abuse treatment rates for
prescription opiate use in 2010 was seven times what it was a
decade earlier, and opiate-related overdose deaths in Nebraska
are rapidly approaching the number of deaths due to automobile
accidents [5]. In neighboring Missouri, overdose deaths have
exceeded automobile deaths for several years [5].
Understanding and preventing health-related harms arising
from drug use is complex [6, 7]. Years of addiction studies point
to multifactorial causes for drug abuse, ranging from altered
neurological function [8], behavioral factors [9, 10] and psychosocial determinants [11], all operating in complex feedback
loops. Complicating this are the physical, social, and emotional
effects of blood born infections such as HIV, hepatitis B and C
and tuberculosis, as well as a longer list of sexually transmitted
infections frequently contracted in the context of drug use [12].

Although many human-system/virus-system interactions are
now understood [13], how these are embedded in specific social
contexts often remains unknown [14].
The few studies of rural drug use that exist show marked
differences in rural versus urban drug users across demographic
variables such as age or gender [15, 16] and large discrepancies
in both the contexts of drug use and patterns of drug-related
health consequences [17-19]. Other less direct disparities include
differing social stressors, lower overall health levels and health
care access, a dearth of substance use treatment facilities [20],
unstable incomes, sparse social networks, and continuing high
levels of social stigma around drug use and its related infections
[21]. All of these mark rural drug use as vastly different from use
in urban areas. Despite a small number of important exceptions
[15, 18, 20], the urgent challenge of understanding drug use in
rural settings is significantly under-examined.
The Problem: The United States’ relationship with drugs is
woven into our national history [22], from tobacco and rum to
coffee and stimulant-laced drinks, to the use of performance
enhancing drugs in our national pastime. Further, moral, health,
economic, and psychological questions around drugs have
been continually raised and disputed. This consistency does not
reflect stasis, however. The nature and challenge of drug use
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continues to change rapidly [23], evolving in location and time
in reaction to enforcement and education that would curtail use
and driven forward by consumer demand and high profits [24].
Because much of this demand (and profit) is rooted in personal
addiction, debates about drug use invoke individual and ethical
dimensions not associated with other health issues. Recent
findings on rising rates of white male mortality, in part due to the
increasing numbers of drug-related deaths, has once again raised
the question of America’s relationship with substance abuse [25]
and drugs as they reflect or contribute to national moral decline
[26-30].
Beneath the public furor, however, the health sciences have
made considerable progress in understanding the etiology of
drug use and in uncovering the link between drug use and its
myriad associated harms. To name only a few areas of progress,
the last three decades have seen remarkable advances in the
neurochemistry of drug effects, the virology of pathogens whose
spread is often rooted in drug use [13], the understanding of social
determinants of drug initiation [31] and clinical approaches to
drug cessation. Researchers now speak openly and optimistically
about an HIV vaccine and a cure for AIDS. Safer and more
reliable forms of opiate inhibitors are emerging every year and
as the National Institute on Drug Abuse (NIDA) points out, drug
treatment effectiveness is now on par with the success rates of
treatments for diabetes and asthma [32].
However, this promising scientific news has not always translated
to better health outcomes. An outbreak of HIV infection in
southern Indiana in 2015 revealed surprisingly widespread rural
drug injection [33]. Current estimates of this outbreak are that
40 percent of the local network of people who inject drugs were
infected in less than four months, a scenario not witnessed in
urban areas since the early 1980s [33, 34]. The risks go beyond
HIV and Clark County, Indiana, where the majority of cases
were located. A medical state of emergency was declared in
neighboring Madison County based on a high prevalence of
hepatitis C virus (HCV) infection discovered in the process of
understanding the HIV outbreak [34].
Nationally, overdose-related deaths and rates of opiate addiction
in the United States are once again near record highs [35], a
situation that Department of Health and Human Services (DHHS)
Assistant Secretary Richard Frank recently identified as a top
priority for the Administration and DHHS as a whole [36]. Even
progress in slowing the use of cocaine cannot mask the immense
growth in the use of other stimulants such as methamphetamine
[37]. Today, the diversion of prescription and over-the-counter
medicines into the illicit drug market is more prominent than at
any time since regulation began [38].
These issues are exacerbated by changes in use patterns that
have seen a dramatic increase in the use of illicit drugs in rural
and sub-urban areas [39]—a change that (perhaps relatedly)
locates problems of addiction and drug-related harms in those
regions where overall health care infrastructure is struggling to
remain viable. As a result, and in ways not seen before, rural drug
use has come to urgent national attention. Data on rural drug
use and its harms justify this attention. Methamphetamine use
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in Nebraska, Oklahoma, Iowa, and Missouri now rivals any region
in the US [4]. Substance abuse treatment needs in rural states
dwarf available services [5], and overdose rates in rural states in
the Central Plains exceed 30 deaths per 10,000 residents in some
rural counties [40]. Arrest data for cocaine, methamphetamine,
or heroin possession in rural counties in the region are similar to
urban zones with similar patterns of drug use such as Maricopa
County Arizona, and Dallas, Texas [41].
Comparisons of rural to urban drug use within Nebraska show
that rural users start using drugs at a younger age, are more likely
to use and sell methamphetamine, and use non-marijuana illicit
drugs at a higher rate than their urban counterparts [16, 42]. Their
methods of use are more risky as well. Between 40 and 50 percent
of rural methamphetamine users in Nebraska prefer injectionbased use, nearly twice the urban rate and a similar ratio was
found for lifetime rates of methamphetamine-related psychosis
[16, 43]. Daily count methadone use in Nebraska in 2012 was four
times the rate of 2008 and overall estimates suggest that only 8.6
percent of illicit drug-dependent individuals received treatment
during 2012 [43]. In all, 3,594 Nebraskans and 8,131 Iowans were
admitted for treatment for cocaine, methamphetamine, and
opiate abuse in 2013, with methamphetamine by far the most
common.
Like rural Indiana prior to the 2015 outbreak, rates of HIV are
low in Nebraska, Iowa, and Kansas. However, risk is high. All of
these states have highly restrictive syringe access laws [44-46]
and high treatment deficits [47, 48]. The current treatment needto-capacity ratio for opioid addiction in Nebraska is nearly 6:1,
ranking third worst in the United States behind Arkansas and
South Dakota (each roughly 7:1) and well behind treatment
capacity in Connecticut, Massachusetts, and New York, where
ratios are roughly 1:1 [49]. Together, these factors foster
significant vulnerability to outbreaks like that seen in Indiana and
in other rural states [50]. While little surveillance information is
available for rural areas in the Central Plains, data from regions
with similar use patterns suggest HCV rates of 40 to 50 percent
among rural injectors [51-53]. This marks both a hidden precursor
to the HIV risk made possible by current drug use patterns and a
serious health crisis in the making.
To address this issue, we need to recognize that clear differences
exist for rural drug use that make most urban intervention
programs ineffective. These differences include: 1) the settings
in which drug use takes place (i.e., social, moral, economic,
geographical, and environmental contexts); 2) the patterns of
use and demographics of rural drug users; and 3) the conditions
and capacities for treatment, intervention, and general care.
Rural Contexts and Drug Use: Elevated levels of behavioral risk
for residents of rural areas has been recognized among youth
[54] and adults [39, 55], although it is also widely recognized
that data on rural risk remain uneven and insufficient [56].
Efforts to understand geographical differences as they influence
drug-related risks point to a range of “social ecological” factors
underlying these differences [57, 58]. For example, according to
Keyes and colleagues [59], the concentration of opiate abuse in
rural areas is tied to general structural factors that differentiate
This article is available in: http://drugabuse.imedpub.com/archive.php
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rural areas from cities, including: 1) higher rates of opioid
prescription, 2) youth outmigration, 3) larger kinship networks
that facilitate informal drug trafficking, and 4) more economic
stress.
Other approaches note macro-level social structural factors
(e.g. marked differences in prisoner re-entry outcomes) for rural
areas [60] or differences in rural drug policing [61]. Still others
point to radically different racial [62, 63] and economic dynamics
[64] related to rural use and risk patterns—factors that require
different treatment and intervention strategies. However, not all
research takes the urban/rural divide as paramount. Research
on rural methamphetamine use points to the importance of
local social contexts in creating micro-locational differences
within rural areas [65], and research on rural cocaine use
finds significant population level differences between users of
different stimulants and their respective risk profiles [62]. Some
recent evidence even looks at genetic-environment interactions
and how these affect substance use susceptibility in rural
areas [66, 67]. These approaches could also shed light on rural
concentrations of drug use from genetic ‘founder effects.’ Such
findings point to an important consideration—that the causes
and implications of rural drug use are highly variegated and may
be as different from one region to another, or even one county to
another, as they are from generalized urban trends.
Rural Patterns of Drug Use and Demographics of Rural Users:
When we shift the focus to rural drug users themselves, there
is again evidence of systematic differences between urban and
rural areas, including who uses drugs and how [23, 68]. In a wide
ranging series of studies in Appalachia, Havens and colleagues
found marked differences between rural and urban drug users
(mainly users of prescription opiates) in transitions from first
use to first injection [17], patterns of initiation of opioids and
polysubstance use [15, 69], gender propensities [70], and HCV
infection [71], even while patterns of non-fatal overdose were
similar [72]. Others have found significant rural/urban differences
for methamphetamine users [65]. In Nebraska, Kansas, and Iowa,
treatment admissions for methamphetamine are nearly equal
for men and women [73], a startling contrast with other drugs
and other regions. According to the Treatment Episodes Data Set
(TEDS 2013), in Nebraska, one third of drug treatment admissions
were for stimulants, and amphetamines were second only to
alcohol in total treatment admissions [47]. Grant and colleagues
found that rural methamphetamine users in the state were nearly
twice as likely to only inject as their urban counterparts were
(37.2 percent versus 20.2 percent) [16]. This risk profile implies
radically different potential for HIV and related harms should
the virus enter these communities. Other harms have already
taken place: in the same report, Grant and colleagues found that
lifetime prevalence for meth-related psychosis was much higher
for rural (44.9 percent) than urban (28.7 percent) individuals,
despite similarities across all other mental health areas [74].
Research on factors influencing user differences within rural
areas has focused on many of the same issues that differentiate
use among urban populations. Meyers found that adolescent
risk and support factors for stimulant users differed along
© Under License of Creative Commons Attribution 3.0 License
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racial lines [75, 76], while Pope found differences for this group
were (also) patterned by gender [77]. In both cases, similarities
between urban and rural drug users were clear. These results
point to an important conclusion—rural users require special
consideration for multiple reasons, including decidedly higher
rates of methamphetamine use, a higher proportion of users
preferring injection, and a user population that is younger and
riskier than urban counterparts [51, 78]. This conclusion holds
true regardless of whether greater differences exist between
urban and rural drug use, or within rural areas themselves,
Rural Capacities for Treatment, Intervention, and Care: Several
of the above issues contribute to low treatment success rates
in rural areas. In looking at differences within rural areas, Oser
and Harp discovered that cultural differences between home and
treatment venues played a large role in rural treatment outcomes
[79], findings echoed by McMaster for female methamphetamine
users [80]. Jackson and Shannon, on the other hand, noted few
differences in treatment seeking attitudes in rural versus urban
pregnant women [81]. Rather, in their view, and in the view of
others, these outcomes for rural treatment seekers may simply
reflect a shrinking rural health care infrastructure [21, 64] and
decades of general mortality differences across the full continuum
of rural settings [82]. There are reasons to suspect this is the case,
including a documented lack of available substance use disorder
treatment facilities [83] and drug education programs [84] in
rural counties. However, these may be only part of the problem,
as the treatment needs caused by drug use often go beyond
the actual user, affecting family, community, and environment
[85]. These findings point to rural conditions that require specific
attention to regional issues and differences within rural drug
using populations. At the same time, we must keep in mind the
clear evidence that larger structural features distinguish rural
from urban zones, including differences in care.
In the United States, drug use and its associated health risks have
traditionally been considered an urban problem. For example,
the Centers for Disease Control and Prevention (CDC)’s National
HIV Behavioral Surveillance (NHBS) Program on Injection Drug
Use focuses entirely on the nation’s 25 largest urban areas,
performing extensive surveillance testing among drug using
populations in each of these cities every three years. In
contrast, drug-related disease surveillance in non-urban
zones is largely restricted to local law enforcement programs.
In many rural areas, non-prison surveillance is non-existent.
In the past, this emphasis on urban drug use has been justified
by low rates of drug-related health impacts in non-urban zones.
However, the evidence of the last five years shows that this is no
longer the case.

Discussion
Rural injection drug use and its related harms have come to
national attention at the same time that drug use in the United
States has undergone a radical reformulation. New clusters of
prescription opiate users (23), significant numbers of whom
transition to heroin and the near ubiquity of methamphetamine
abuse across rural parts of the country [86] have transformed
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the national health landscape. Both of these phenomena have
significantly impacted the Central Plains, a region one recent
author refers to as “Methland” (22) for the sheer scope of use
and for its intense impact in a quickly changing rural economic
landscape. The harms associated with the use of these drugs
goes beyond the more well-known viruses, with implications
for sexually transmitted infections contracted in the context of
drug use [87], mental health problems [88], and other social and
family harms that ripple out from personal centers of addiction
[89] (Table 1).
Despite timely and pressing challenges related to rural drug
use, there are crucial limitations in the current state of research
surrounding this issue. These challenges must be addressed if we
hope to impact rural drug use. In general, the need for reliable
physical, contextual and cognitive data related to the onset and
desistance of drug use (and behaviors associated with drug use
harms) is particularly critical for research on rural illicit drugs
users [90]. Indeed, a significant amount of what we know about
drug use in urban areas is based on successful, long-term cohort
studies [90, 91], some of which continue today such as ALIVE [92],
MIX [93] and VIDUS [94]. However, no rural equivalent currently
exists and past rural studies have focused mainly on Appalachia [18].
When we look at the 32 counties in eastern Nebraska, western
Iowa, and northern Kansas, we get a sense of the immensity of
the challenge. By scaling up [95-97] drug-related (non-marijuana)
arrest data from the Department of Justice's Uniform Crime
Reporting Program (UCRP; [77]) and hospitalization data from
the Substance Abuse and Mental Health Services Administration
(SAMHSA; [78]), we can estimate the size of the drug using
population in these counties to be ~20,000 individuals (which is ~
2.7 percent of the counties’ population of ~ 740,000). This figure
is commensurate with national prevalence estimates of drug use
as a percentage of total population [79].
While research is needed, immediate solutions to the health risks
posed by rural drug use are available. Modern day harm reduction
points to three basic means for minimizing the personal and
social risks associated with drug use, especially injection drug use
preventative strategy. This startlingly contradictory position was
underwritten by entrenched (and essentially irrational) opinions
about syringe exchange programs—namely, the idea that making
clean needles available in exchange for dirty ones somehow
encourages drug use among those not already using drugs, or
that it increases the level of drug use among those already using.
This has been shown repeatedly and uniformly to be false in both
cases [98]. To be clear, there is no evidence in three decades of
research to suggest either assumption, yet it governs policy in
Table 1 The scope of illicil drug use in 32 contagious countries of
eastern Nebraska, Western lowa and northern Kansas.
Number of countries
Population of countries (P)
Arrests related to drugs (UCRP)
ER admissions for drug use (SAMHSA)
Est. drug user pop. size (5% arrest rate)
Est. drug user pop. size (15% ER rate)
Drug user pop. size as percentage of P

4

32
740,705
978
3.050
19,560
20,333
2.7%
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nearly half of the states in the US, and nearly all states in the
Central Plains. This is clearly one of area of public health where
rational, data-driven outcomes have yet to be adopted in public
policy arenas, and thus an area where immediate progress could
be made that would save lives and lower treatment costs, even
while it protects the wider non-using public from potentially
dangerous outbreaks of HIV or hepatitis C. Temporarily closing
the barn door long after the horse has left, as was done in Indiana,
is unlikely to prevent HIV and hepatitis C outbreaks in places like
Nebraska, Missouri, Kansas, Oklahoma or Iowa and much of the
Central and Northern Plains [99].
Opiate substitution treatment: Treatment of opiate addiction has
included opiate substitution for more than five decades. Among
the earlier methods was methadone treatment, an opiate that
produces less of a “high” that is used in measured and medically
supervised program lessen the effects of heroin or opiate
withdrawal. Its effectiveness was debated for years, but recent
retrospective reviews have found that methadone substitution
treatment was highly effective not just in treating addiction,
but in lowering on-going risk for infection during the treatment
period and beyond [100].
New treatments using substitution drugs such as buprenorphine
have proven even more effective than methadone, and have
longer lasting success rates. Buprenorphine is a partial opiate
agonist, meaning that it bonds to neurological receptors in the
brain in a way that is similar to opium (or heroin or a range of
opiate-based prescription pain killers), but does not produce the
same effects as opiates (i.e., the opiate delirium experienced as a
“high”) [100]. It is thus highly effective in staving off withdrawal
symptoms without fulfilling the psychological need for escape.
By lessening withdrawal effects, buprenorphine allows the user
to gradually reduce use and “ease off” of the drug, normally
while receiving addiction therapy aimed at understanding and
lessening the causes of psychological addiction. By allowing
the latter (psychological addiction) to be treated without the
experience of withdrawal (physiological addiction), the user
stands a greater chance of successfully confronting those issues
that inspired drug use/initiation in the past.
Despite these successes, buprenorphine treatment is very rare
in the Midwest and Central Plains. Because treatment takes
place in a doctor’s office and under medical supervision, the
availability of treatment is dependent on sufficient numbers of
doctors who are willing to participate. Arkansas, North Dakota
and Nebraska rank worst in the US in terms of the ratio of opiate
addicts to buprenorphine prescribing doctors. This is partly due
to the scope of the opiate addiction problem in these states,
and partly due to lack of rural medical infrastructure. In some
ways, the lack of buprenorphine prescribing doctors reflects the
general lack of medical services in rural areas, but in the situation
is exaggerated by the stigma attached to drug use and addiction.
This is particularly troubling because in these states, opiate
addiction is increasingly a rural problem.
This too is a solvable problem, but one that currently lacks political
attention. By allowing and promoting buprenorphine services in
existing rural facilities, successful treatment for growing opiate
This article is available in: http://drugabuse.imedpub.com/archive.php
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addiction in the region could be expanded dramatically in the
Central Plains. Given that the treatment is covered by virtually
all public and private forms of insurance, the cost to these states,
after the initial training and implementation, would be minimal—
and the savings in lost productivity time, emergency room visits,
and general public risk for drug use related diseases would be
substantial.
Naloxone: Where buprenorphine is a partial opiate agonist,
naloxone (often known under the commercial name of Narcan)
is an opiate antagonist. This means that it operates by blocking
the attachments of opium to neurological receptors. In effect,
naloxone prevents opium from having an effect on the brain. For
this reason, it is often used in emergency situations to reverse an
overdose.
As discussed above, drug overdose rates in the Central Plains have
grown dramatically over the last decade. Missouri, Oklahoma and
Wyoming have rates of overdose nearly double the rates of New
York, California, Texas, or Virginia and nearly double the rates of
Eastern rural states that have receive considerably more public
attention such as Vermont. Notably, some states in the Central
Plains still do not make naloxone available to the public, nor
have they passed “Good Samaritan” laws protecting bystanders
who report overdose incidents to emergency services, or who
administer naloxone to someone who has overdosed.
Unlike syringe exchange or buprenorphine availability,
considerable progress has been made in this area, however.
Central Plains states with high levels of overdose have taken

© Under License of Creative Commons Attribution 3.0 License
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action to make overdose deaths less likely by making naloxone
more available and its use in an emergency more protected.
Holdouts continue, though, including Missouri, Kansas, South
Dakota, Iowa, Minnesota and Wyoming. This is difficult to
understand, other than to point out the overall punitive attitude
toward addicts in these states. Again, there now exist easy and
low cost means to mitigate the relationship between drug use
and overdose death, held back only by a seeming desire to punish
addicts for their addiction.
Taken together, these three inexpensive and cost effective
programs could greatly reduce the disease risk of injection drug
use, facilitate addiction recovery, and reverse the rising rate of
accidental death associated with overdose. All of these programs
have been employed in other regions with considerable success,
and with none of the feared side-effects of increased drug use.
The lesson that we need to recognize in Nebraska and the Central
Plains is that data driven means for dealing with rising rural drug
use in our region are available, and acting only after the problem
can no longer be ignored ensures that these means will cost more
and be more widely needed. In short, the time to act is now.
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